Aussie medical cannabis company raises AU$10 million

Australian medical marijuana firm MGC Pharmaceuticals raised 10 million Australian dollars ($7.7 million) to foster development of MMJ products and purchase other companies

According to Business Insider Australia, the medical grade cannabis company will use the funds for clinical trials and research and development involving pharmaceutical-grade MMJ products.

MJBizConThe company is also seeking acquisition prospects at home and abroad in the MMJ industry, Business Insider Australia reported.

MGC Pharmaceuticals has experience working with the Israeli medical cannabis market and works with high-CBD strains to create extracts, including resins and oils.

Last year, the firm signed a distribution deal in California for more than 60,000 units of CBD-based anti-aging cosmetic products, according to Proactive Investors Australia.

Daily News | Briefs | Marijuana Stocks & Public Companies | Medical Cannabis Business & Marijuana Legal News in Other Regions | Sales, Funding & Banking News

Leave a Reply

Your email address will not be published. Required fields are marked *

Please note: Comments are moderated by our editors who do their best to approve comments ASAP. As Marijuana Business Daily is focused on business, we approve comments that are specifically relevant to industry professionals. General opinions and questions about cannabis may not be posted.